Who makes PG4 in Buffer 1 with high dose PA-001?

PG4 in Buffer 1 with high dose PA-001 is developed by Pfizer Inc..

What development phase is PG4 in Buffer 1 with high dose PA-001 in?

PG4 in Buffer 1 with high dose PA-001 is in Phase 1.

What is the generic name of PG4 in Buffer 1 with high dose PA-001?

pg4-in-buffer-1-with-high-dose-pa-001 is the generic (nonproprietary) name of PG4 in Buffer 1 with high dose PA-001.

Last reviewed 2026-04-20 · How we verify

PG4 in Buffer 1 with high dose PA-001 (pg4-in-buffer-1-with-high-dose-pa-001)

Pfizer Inc. · Phase 1 active Vaccine Quality 0/100

At a glance

Generic name	pg4-in-buffer-1-with-high-dose-pa-001
Sponsor	Pfizer Inc.
Modality	Vaccine
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study to Learn About How a New Pneumococcal Vaccine Works in Adults (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PG4 in Buffer 1 with high dose PA-001 CI brief — competitive landscape report
PG4 in Buffer 1 with high dose PA-001 updates RSS · CI watch RSS
Pfizer Inc. portfolio CI